These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 15183334

  • 1. Applications of high-throughput ADME in drug discovery.
    Kassel DB.
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [Abstract] [Full Text] [Related]

  • 2. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL.
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [Abstract] [Full Text] [Related]

  • 3. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J, Skolnik S.
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [Abstract] [Full Text] [Related]

  • 4. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H.
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [Abstract] [Full Text] [Related]

  • 5. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.
    Nassar AE, Kamel AM, Clarimont C.
    Drug Discov Today; 2004 Dec 01; 9(23):1020-8. PubMed ID: 15574318
    [Abstract] [Full Text] [Related]

  • 6. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C, Reichel A.
    Chem Biodivers; 2005 Nov 01; 2(11):1462-86. PubMed ID: 17191947
    [Abstract] [Full Text] [Related]

  • 7. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J.
    Int J Clin Pharmacol Ther; 1999 Dec 01; 37(12):575-83. PubMed ID: 10599949
    [Abstract] [Full Text] [Related]

  • 8. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Sep 01; 43(9):898-904. PubMed ID: 19048779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lead optimization strategies as part of a drug metabolism environment.
    Korfmacher WA.
    Curr Opin Drug Discov Devel; 2003 Jul 01; 6(4):481-5. PubMed ID: 12951811
    [Abstract] [Full Text] [Related]

  • 12. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ, Ertl P, Lewis R.
    Drug Discov Today; 2011 Jan 01; 16(1-2):65-72. PubMed ID: 21074634
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development.
    Ekins S, Williams AJ.
    Lab Chip; 2010 Jan 07; 10(1):13-22. PubMed ID: 20024044
    [Abstract] [Full Text] [Related]

  • 15. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.
    Palucki M, Higgins JD, Kwong E, Templeton AC.
    J Med Chem; 2010 Aug 26; 53(16):5897-905. PubMed ID: 20527889
    [No Abstract] [Full Text] [Related]

  • 16. New horizons in drug metabolism, pharmacokinetics and drug discovery.
    Palmer AM.
    Drug News Perspect; 2003 Aug 26; 16(1):57-62. PubMed ID: 12682673
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The role of ADME evaluation in translation research of innovative drug].
    Liu Y, Hong L, Yu LS, Jiang HD, Chen JZ, Meng Q, Chen SQ, Zeng S.
    Yao Xue Xue Bao; 2011 Jan 26; 46(1):19-29. PubMed ID: 21465804
    [Abstract] [Full Text] [Related]

  • 19. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE, Talaat RE, Kamel AM.
    Curr Opin Drug Discov Devel; 2006 Jan 26; 9(1):61-74. PubMed ID: 16445118
    [Abstract] [Full Text] [Related]

  • 20. Mitigating permeability-mediated risks in drug discovery.
    Wang J, Skolnik S.
    Expert Opin Drug Metab Toxicol; 2010 Feb 26; 6(2):171-87. PubMed ID: 20064074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.